Literature DB >> 21923443

Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.

Gregory J Hughes1, Priti N Patel, Neera Saxena.   

Abstract

Warfarin is known to have extensive interactions with many classes of drugs. The literature suggesting a relevant interaction between acetaminophen and warfarin is inconsistent. Considering the ubiquitous use of acetaminophen, a review of the effects on international normalized ratio (INR) in patients taking warfarin was necessary. Thus, we performed a search of the PubMed (1966-November 2010) and International Pharmaceutical Abstracts (1970-November 2010) databases to review the available literature addressing an acetaminophen-warfarin interaction and its possible mechanisms. A sample of case reports, in addition to all English-language studies were evaluated, and relevant references were examined for additional articles. Reports of nonwarfarin coumarin anticoagulants were excluded. Published documentation reporting an interaction between acetaminophen and warfarin is limited. Small prospective studies of various designs and case studies describe aberrant INR results in patients using acetaminophen while receiving warfarin. These INR elevations typically involved acetaminophen ingestion of at least 2 g/day for several consecutive days. In several small prospective studies, INR results were elevated to a statistically significant extent that would require a change in warfarin dosing and monitoring in clinical practice. The mechanism for this interaction remains to be elucidated yet is suggested to occur through alterations in hepatic metabolism. The use of moderate-to-high doses of acetaminophen while receiving warfarin results in supra-therapeutic INRs in some patients. The characteristics that may predispose a patient to this interaction are unclear, yet the widespread use of acetaminophen calls for enhanced clinician awareness and reinforcement of patient education about this interaction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21923443     DOI: 10.1592/phco.31.6.591

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.

Authors:  Heidi Taipale; Hanna Vuorikari; Antti Tanskanen; Marjaana Koponen; Jari Tiihonen; Raimo Kettunen; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

Review 2.  Antithrombotic drugs: pharmacology and implications for dental practice.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2013

3.  Identification and weighting of the most critical "real-life" drug-drug interactions with acenocoumarol in a tertiary care hospital.

Authors:  L Gschwind; V Rollason; C Lovis; F Boehlen; P Bonnabry; P Dayer; J A Desmeules
Journal:  Eur J Clin Pharmacol       Date:  2012-08-19       Impact factor: 2.953

4.  Warfarin and acetaminophen interaction in a 47-year-old woman.

Authors:  Derek Leong; Peter E Wu
Journal:  CMAJ       Date:  2020-05-11       Impact factor: 8.262

5.  Describing the profile of patients on concurrent rifampin and warfarin therapy in western Kenya: a case series.

Authors:  M W Maina; S D Pastakia; I Manji; N Kirui; C Kirwa; Rakhi Karwa
Journal:  Drugs R D       Date:  2013-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.